selumetinib
Showing 26 - 50 of 59
Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)
Completed
- Lung Cancer
- +7 more
- Selumetinib
- +2 more
-
Chicago, Illinois
- +5 more
Nov 15, 2019
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- +2 more
- AZD4547
- +10 more
-
Aberdeen, United Kingdom
- +24 more
Nov 2, 2021
Differentiated Thyroid Cancer Trial in Worldwide (Selumetinib, Placebo, Radioactive Iodine Therapy)
Terminated
- Differentiated Thyroid Cancer
- Selumetinib
- +2 more
-
Birmingham, Alabama
- +44 more
Aug 27, 2019
Colorectal Tumors, Gastrointestinal Tumors, Pancreatic Tumors Trial in Nijmegen, Amsterdam (Afatinib, Selumetinib, Docetaxel)
Unknown status
- Colorectal Neoplasms
- +3 more
- Afatinib
- +2 more
-
Nijmegen, Gelderland, Netherlands
- +1 more
Aug 24, 2018
NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)
Completed
- Non-small Cell Lung Cancer (NSCLC)
- selumetinib
-
Tainan, Taiwan
- +2 more
Jul 9, 2018
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +3 more
- Diagnostic Laboratory Biomarker Analysis
- Selumetinib
-
Los Angeles, California
- +71 more
Jul 19, 2019
Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer
Withdrawn
- Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
- +2 more
- Selumetinib
- +2 more
- (no location specified)
Mar 14, 2018
Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)
Completed
- Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
- selumetinib
- +4 more
-
Glasgow, United Kingdom
- +3 more
Mar 12, 2018
Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial
Completed
- Recurrent Thyroid Gland Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- Selumetinib
-
Tampa, Florida
- +5 more
Dec 2, 2016
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Ocular Melanoma With Extraocular Extension Trial in Canada, United
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,
Terminated
- Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
- Cisplatin
- +2 more
-
Kashiwa Shi, Chiba, Japan
- +1 more
May 5, 2016
Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)
Completed
- Biliary Tract Neoplasms
- +2 more
- selumetinib
- +2 more
-
London, United Kingdom
- +2 more
May 11, 2016
Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer
Completed
- Liver and Intrahepatic Biliary Tract Cancer
- +2 more
- selumetinib
- laboratory biomarker analysis
-
Tampa, Florida
- +6 more
Mar 22, 2016
Adult Solid Tumor Trial in Baltimore (biological, other, drug)
Completed
- Adult Solid Neoplasm
- Cixutumumab
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016
Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )
Completed
- Solid Tumours
- Selumetinib
- +2 more
-
Overland Park, KansasResearch Site
Oct 7, 2015
Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)
Terminated
- Recurrent Adult Diffuse Large Cell Lymphoma
- Laboratory Biomarker Analysis
- Selumetinib
-
Chicago, Illinois
- +15 more
Jan 4, 2016
Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)
Completed
- Solid Tumours
- selumetinib
- +2 more
-
Overland Park, KansasResearch Site
Jun 29, 2015
Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United
Completed
- Recurrent Adult Soft Tissue Sarcoma
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Beverly Hills, California
- +7 more
Sep 4, 2015
Solid Tumours Trial in Orlando (selumetinib)
Completed
- Solid Tumours
- selumetinib
-
Orlando, FloridaResearch Site
Jun 29, 2015